AOC3 and cancer: The adjusted HR per 1 SD increase in serum VAP-1 concentrations in the model developed by forward, backward, and stepwise selection was 1.29 for cancer incidence (95% CI = 1.03–1.08), 1.60 for cancer mortality (95% CI = 1.16–2.19) and 1.39 for all-cause mortality (95% CI = 1.12–1.73).